Pfizer Triumphs in $10 Billion Race for Metsera, Betting Big on Next-Generation Weight-Loss Drugs
In one of the year’s most closely watched pharmaceutical deals, Pfizer Inc. has agreed to acquire Metsera, a fast-growing biotech firm specializing in metabolic and
by 
Josh Weiner
Josh Weiner